Pfizer Inc 2024 SR
The report highlights Pfizer's progress in 2024 toward responsible business growth, reaching over 414 million patients with medicines and vaccines. Key achievements include advancing a robust pipeline with 115 programs in development and receiving 14 approvals from the FDA and EMA. The company accelerated its net-zero ambition to 2040, with 65% of suppliers now committed to science-based emission reduction targets. Pfizer also celebrated its 175th anniversary, emphasizing its commitment to health equity through initiatives like the Accord for a Healthier World and the 'Change the Odds' cancer program.
Company: Pfizer Inc
Sector: Health Care
Country: United States
Year: 2024
Type: SR
Pages: 82
Pfizer Inc
Impact Report
The report highlights Pfizer's progress in 2024 toward responsible business growth, reaching over 414 million patients with medicines and vaccines. Key achievements include advancing a robust pipeline with 115 programs in development and receiving 14 approvals from the FDA and EMA. The company accelerated its net-zero ambition to 2040, with 65% of suppliers now committed to science-based emission reduction targets. Pfizer also celebrated its 175th anniversary, emphasizing its commitment to health equity through initiatives like the Accord for a Healthier World and the 'Change the Odds' cancer program.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target